…Sweden, Denmark, Norway and Germany, MAX IV and ESS in Sweden, DESY, the European XFEL in Germany, the Medicon Valley Alliance (MVA), industry in MedTech, BioTech and Pharma, Region Skåne, the Capital Region of Denmark and the City of Hamburg. In…
…EST@maxiv.lu.se if you have queries or require support. Complete Safety Test The safety training is mandatory for gaining access to the MAX IV building. Download the reading materials for your…
…and leading scientists from Aarhus University, Technical University of Denmark (DTU), University of Copenhagen, University of Gothenburg and Lund University. The proposal was supported at these universities by the leadership…
…The FEL in the SXL project at MAX IV J. Synchrotron Rad. 28, 707 – Published May 2021 Weilun Qin, Francesca Curbis, Joel Andersson, Vitaliy Goryashko, Lennart Isaksson, Billy Kyle,…
The fluid in your gastrointestinal tract is a complex soup of biomolecules. When you take a pharmaceutical drug, the biomolecules may stick to its surface and alter how it’s dissolved…
…measurements with X-ray absorbance spectroscopy (XAS) were taken at beamline I811 at Max-lab in Lund, Sweden and X-ray Absorption Near-Edge Structure (XANES) spectra at beamline ID26 at the European Synchrotron…
…what substrates are relevant to test activity on, where small model compounds do not properly mimic the more complex cell wall,” said Johan Larsbrink, study researcher and associate professor of molecular…
Prepare for a successful PRISMAS application by writing a compelling cover letter and gathering the required documents. Here is everything you need to know to start your PRISMAS journey. When applying for…
…used X-ray absorption spectroscopy techniques (XANES and EXAFS) at the Balder beamline at MAX IV. Cobalt-toughened cemented carbide inserts coated with a TiAlN compound were prepared as samples. Each contained…
…was and still is awesome. The fact that we could convert a weak (about 500 µM) affinity fragment to a potent lead compound by medicinal chemistry and X-ray crystallography is…